glp 1 parkinson's A New Treatment Strategy for Disease through the Gut–Brain Axis: The Glucagon-Like Peptide-1 Receptor Pathway When the scale drops in
Description
[47] Reiffen, D., & Ward, M
Some patients may experience rebound effects or find that their bodies develop resistance to the medication
They try to get by on caffeine, a shake, and willpower
Your healthcare team will monitor blood pressure regularly at medication reviews, check kidney function through blood tests, measure HbA1c every 36 months, and track weight
For more tips, be sure to subscribe to our newsletter at the bottom of our site, and stay up to date with us on social media as we help you #LoveYourGuts all year round!
